Regulatory clearance creates an at-home, 28-day cycle option using oral decitabine/cedazuridine on days 1–5 plus venetoclax 400 mg daily after a ramp-up cycle. Efficacy signals in ASCERTAIN-V included ...
Formal adoption of PMOS replaces a cyst-centric label with terminology capturing endocrine, metabolic, and ovarian dysfunction that drives infertility, menstrual irregularity, and long-term ...
Food insecurity identification modeling for Medicare can establish a reliable method of prioritizing members at risk of food ...
RBM20 truncating variants ( RBM20 tvs) appear to contribute to arrhythmogenic dilated cardiomyopathy (DCM) but with ...
In part 2 of her interview with The American Journal of Managed Care®, Deborah Doroshow, MD, PhD, assistant professor of ...
Placebo-controlled evidence across 9013 patients showed a lower composite risk (HR 0.85) driven by reduced worsening HF ...
Women with endometriosis have an elevated risk of developing epithelial ovarian cancer, but, when they do develop it, they ...
Santa Clara County Public Health issued a South Bay health alert after 18 Legionella cases were linked to Kaiser Santa Clara, ...
Scott Shannon, MD, discusses psychedelic therapies, federal policy shifts, and the barriers slowing mental health innovation.
Meanwhile, ctDNA, a subset of cell-free DNA shed by tumors into the bloodstream, has emerged as a promising non-invasive risk stratification tool. Detection of ctDNA following curative-intent surgery, ...
Young adults with early-onset colorectal cancer (EOCRC), particularly men and non-Hispanic Black and American Indian/Alaskan ...
Anton M. Kolomeyer, MD, PhD, a retina specialist at NJRetina, spoke with The American Journal of Managed Care ® about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results